Table:
begin	end	state
1	19	cytoplasmic
20	40	transmembrane
41	51	non-cytoplasmic
52	71	transmembrane
72	76	cytoplasmic
77	94	transmembrane
95	98	non-cytoplasmic
99	118	transmembrane
119	124	cytoplasmic
125	146	transmembrane
147	172	non-cytoplasmic
173	193	transmembrane
194	204	cytoplasmic
205	227	transmembrane
228	232	non-cytoplasmic
233	253	transmembrane
254	277	cytoplasmic
278	297	transmembrane
298	307	non-cytoplasmic
308	328	transmembrane
329	334	cytoplasmic
335	352	transmembrane
353	357	non-cytoplasmic
358	377	transmembrane
378	384	cytoplasmic

Input:
>WP_012405991.1 NCBI__GCF_000020045.1:WP_012405991.1
MTQGQATDWRRLLSLREMGVYYALILLVFVISAVTVYTGRPSYLSLANISNVLYQSSLVA
IIAVAMTVILITGNFDLSVASVAALSAAVLVGLADTLGFWPAALVAMLVSVLAGLLNGAI
VQYLGINAFIVTLGTLTAIRGVVQIYTDGRSLSVETPEALQAMRLFESGRLPIAIPLILI
GAALLFAGIRFLLRARREGRNASPTSLGMIVAGICCLALVYAGGMTLAMPKPVVYMAVFT
LIVWFILSMTNIGRRVYAVGGNPEAARLSGINVKRYKMAGFILCSAAAGFGGILFGSRLG
AVNPTAMQGAELTVIASAILGGTSLFGGAGSVIKTLAGALLLFTLTNGFNILNLGANYQG
VIEGTVVVTAAAIYTVGGSRRGKR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server